Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study

被引：0
|
作者：
Lee, J. G. [1 ,2 ]
Kim, J. G. [3 ]
Park, S. W. [4 ]
Kim, Y. H. [1 ,5 ]
机构：
[1] Inje Univ, Haeundae Paik Hosp, Pusan, South Korea
[2] Paik Inst Clinicla Res, Dept Psychiat, Pusan, South Korea
[3] Maryknoll Med Ctr, Dept Psychiat, Pusan, South Korea
[4] Inje Univ, Paik Inst Clin Res, Pusan, South Korea
[5] Paik Inst Clin Res, Res Grp 1, Pusan, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2011年 / 21卷
关键词：
D O I：
10.1016/S0924-977X(11)70784-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S483 / S484
页数：2
相关论文
共 50 条
  • [1] Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
    Lee, Jung Goo
    Lee, Sae Woom
    Lee, Bong Ju
    Park, Sung Woo
    Kim, Gyung Mee
    Kim, Young Hoon
    PSYCHIATRY INVESTIGATION, 2012, 9 (02) : 166 - 173
  • [2] Critics on "Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study"
    Pae, Chi-Un
    PSYCHIATRY INVESTIGATION, 2013, 10 (01) : 98 - 99
  • [3] Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: A 12-week, double-blind, placebo-controlled trial
    Lee, J. G.
    Kim, Y. -H.
    Lee, S. W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 141 - 142
  • [4] A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
    Jeffrey A Lieberman
    Kelly Papadakis
    John Csernansky
    Robert Litman
    Jan Volavka
    Xinwei Daniel Jia
    Allyson Gage
    Neuropsychopharmacology, 2009, 34 : 1322 - 1329
  • [5] Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
    Zhu, Weiwei
    Zhang, Zhanchou
    Qi, Jingfeng
    Liu, Fang
    Chen, Jindong
    Zhao, Jingping
    Guo, Xiaofeng
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1317 - 1323
  • [6] A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
    Lieberman, Jeffrey A.
    Papadakis, Kelly
    Csernansky, John
    Litman, Robert
    Volavka, Jan
    Jia, Xinwei Daniel
    Gage, Allyson
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (05) : 1322 - 1329
  • [7] Adjunctive Memantine Treatment of Schizophrenia A Double-Blind, Randomized Placebo-Controlled Study
    Hassanpour, Fatemeh
    Zarghami, Mehran
    Mouodi, Sussan
    Moosazadeh, Mahmood
    Barzegar, Fatemeh
    Bagheri, Maedeh
    Hendouei, Narjes
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 634 - 638
  • [8] Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial
    Lovera, J. F.
    Frohman, E.
    Brown, T. R.
    Bandari, D.
    Nguyen, L.
    Yadav, V.
    Stuve, O.
    Karman, J.
    Bogardus, K.
    Heimburger, G.
    Cua, L.
    Remingon, G.
    Fowler, J.
    Monahan, T.
    Kilcup, S.
    Courtney, Y.
    McAleenan, J.
    Butler, K.
    Wild, K.
    Whitham, R.
    Bourdette, D.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 715 - 723
  • [9] Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study
    Leal, Gustavo C.
    Souza-Marques, Breno
    Mello, Rodrigo P.
    Bandeira, Igor D.
    Caliman-Fontes, Ana Teresa
    Carneiro, Beatriz A.
    Faria-Guimaraes, Daniela
    Guerreiro-Costa, Livia N. F.
    Jesus-Nunes, Ana Paula
    Silva, Samantha S.
    Lins-Silva, Daniel H.
    Fontes, Mariana A.
    Alves-Pereira, Raiza
    Cordeiro, Vivian
    Rugieri-Pacheco, Sidelcina
    Santos-Lima, Cassio
    Correia-Melo, Fernanda S.
    Vieira, Flavia
    Sanacora, Gerard
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 330 : 7 - 15
  • [10] Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study
    Saint Paul, Laure Peyro
    Creveuil, Christian
    Heinzlef, Olivier
    De Seze, Jerome
    Vermersch, Patrick
    Castelnovo, Giovanni
    Cabre, Philippe
    Debouverie, Marc
    Brochet, Bruno
    Dupuy, Benoit
    Lebiez, Pierre
    Sartori, Eric
    Clavelou, Pierre
    Brassat, David
    Lebrun-Frenay, Christine
    Daplaud, David
    Pelletier, Jean
    Coman, Irene
    Hautecoeur, Patrick
    Tourbah, Ayman
    Defer, Gilles
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 363 : 69 - 76
12345